Fat redistribution and bone abnormalities in HIV-infected patients.
Tebas
Pablo
P
Washington University, 4511 Forest Park, Suite 304, Saint Louis, MO 63108, USA. PTEBAS@im.wustl.edu
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001823:Body Composition; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D019380:Anti-HIV Agents; D005343:Fibrinolytic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D014807:Vitamin D